ClinicalTrials.Veeva

Menu

Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital (CPB-Epi Basel)

University Hospital Basel logo

University Hospital Basel

Status

Enrolling

Conditions

Infections With CPB

Treatments

Other: data collection for treatment data
Other: data collection for microbiological data
Other: data collection for demographic data
Other: data collection for clinical data

Study type

Observational

Funder types

Other

Identifiers

NCT04098133
2019-01548 me19Tschudinsutter;

Details and patient eligibility

About

This retrospective and prospective study is to investigate the incidence of Carbapenemase-producing bacteria (CPB) at the University Hospital Basel, the time to detection of CPB and to initiation of infection control measures, the risk factors associated with carriage of CPB, type and duration of previously administrated antibiotic medication, antibiotic treatment, as well as to assess the outcomes of the affected patients.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with detection of carbapenemase-producing bacteria from January 1st , 2008 until December 31st , 2028

Exclusion criteria

  • Patients with documented refusal of subsequent use of their data

Trial contacts and locations

1

Loading...

Central trial contact

Isabelle Vock, Dipl. med; Sarah Tschudin Sutter, Prof. Dr. MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems